International Medical Device Regulatory Monitor

Abdominal aorta aneurysm (AAA) screening and prognostic tests for breast cancer recurrence may offer benefits to specific populations, but a lack of data on both may be keeping the European network for Health Technology Assessment (EUnetHTA) from making a clear recommendation on their use.